Anterix (ATEX) Revenue (2013 - 2026)

Anterix's Revenue history runs 14 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• Quarterly Revenue rose 40.96% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (up 7.79% YoY) and the FY2026 annual result came in at $6.5 million, up 7.79% from the prior year.
• Revenue was $2.0 million for Q1 2026 at Anterix, up from $1.6 million in the prior quarter.
• Across five years, Revenue topped out at $2.0 million in Q1 2026 and bottomed at $335000.0 in Q1 2022.
• A 5-year average of $1.1 million and a median of $1.3 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue jumped 164.32% — and 2025, when it retreated 7.02%.
• Anterix's Revenue stood at $578000.0 in 2022, then surged by 119.9% to $1.3 million in 2023, then advanced by 23.21% to $1.6 million in 2024, then grew by 0.45% to $1.6 million in 2025, then increased by 24.48% to $2.0 million in 2026.
• Business Quant data shows ATEX's Revenue at $2.0 million in Q1 2026, $1.6 million in Q4 2025, and $1.6 million in Q3 2025.